Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia

被引：12
|
作者：
Ho, P. [1 ]
Khan, S. [2 ]
Crompton, D. [2 ]
Hayes, L. [1 ]
机构：
[1] Northern Hosp, Dept Haematol, Melbourne, Vic, Australia
[2] Northern Hosp, Dept Neurol, Melbourne, Vic, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2015年 / 45卷 / 06期
关键词：
THROMBOEMBOLISM; THROMBOPOIETIN; RISK;
D O I：
10.1111/imj.12765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [21] Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
    Stasi, Roberto
    Murali, Magaral
    Michel, Marc
    Viallard, Jean-Francois
    Giagounidis, Aristoteles
    Janssens, Ann
    Legg, Jason
    Deuson, Robert
    Danese, Mark D.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (01) : 26 - 33
  • [22] Is it the therapy or the disease? Exploring the link between treatment for immune thrombocytopenia and thrombosis
    Pishko, Allyson M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 308 - 309
  • [23] Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
    Roberto Stasi
    Magaral Murali
    Marc Michel
    Jean-François Viallard
    Aristoteles Giagounidis
    Ann Janssens
    Jason Legg
    Robert Deuson
    Mark D. Danese
    International Journal of Hematology, 2012, 96 : 26 - 33
  • [24] Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST)
    Buckley, Niall A.
    Baskaya, Mustafa K.
    Darsie, Marin E.
    NEUROCRITICAL CARE, 2021, 34 (03) : 1103 - 1107
  • [25] Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review
    de Sousa, Diana Aguiar
    Romoli, Michele
    Van Kammen, Mayte Sanchez
    Heldner, Mirjam R.
    Zini, Andrea
    Coutinho, Jonathan M.
    Arnold, Marcel
    Ferro, Jose M.
    STROKE, 2022, 53 (06) : 1892 - 1903
  • [26] Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia
    DasGupta, Ryan K.
    Levine, Lauren
    Wiczer, Tracy
    Cataland, Spero
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (03) : 567 - 576
  • [27] Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials
    Tarantino, Michael D.
    Despotovic, Jenny
    Roy, John
    Grainger, John
    Cooper, Nichola
    Beam, Donald
    Raj, Ashok
    Maschan, Alexey
    Kim, June
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2020, 67 (11)
  • [28] Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies
    Kuter, David J.
    Newland, Adrian
    Chong, Beng H.
    Rodeghiero, Rancesco
    Romer, Monica T.
    Pabinger, Ingrid
    Chen, Yuqi
    Wang, Kejia
    Mehta, Bhakti
    Eisen, Melissa
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (03) : 503 - 513
  • [29] Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment
    Tvito, Ariella
    Bakchoul, Tamam
    Rowe, Jacob M.
    Greinacher, Andreas
    Ganzel, Chezi
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 675 - 678
  • [30] Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report
    Gonzales, Mia
    Pipalia, Amrish
    Weil, Andrew
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2019, 7
12345